Escitalopram
Brand names: Lexapro
Selective Serotonin Reuptake Inhibitors (SSRIs)Key Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
⚠ FDA Black Box Warning
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS — Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of escitalopram or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior.
Emergency Information
Poison Control: 1-800-222-1222
How does Escitalopram work?
Escitalopram is the S-enantiomer (therapeutically active mirror-image form) of citalopram (Celexa). Citalopram is a racemic mixture containing equal parts S-citalopram and R-citalopram. Research showed that essentially all of citalopram's serotonin reuptake inhibition comes from the S-enantiomer, while the R-enantiomer may actually partially counteract the S-enantiomer's effect [1, 4]. By isolating the S-enantiomer, escitalopram provides the therapeutic benefit of citalopram at half the dose.
Like all SSRIs, escitalopram works by blocking the serotonin transporter (SERT) protein on presynaptic neurons. This prevents the reuptake (reabsorption) of serotonin from the synaptic cleft, allowing serotonin to remain available longer to stimulate postsynaptic receptors [1, 4, 12]. The increased serotonergic signaling ultimately leads to downstream neuroplastic changes that relieve symptoms of depression and anxiety.
Escitalopram is considered the most selective SSRI — it has the least off-target binding to other receptors and transporters, which theoretically contributes to its clean side effect profile [1, 4, 12]. It has minimal affinity for histamine, muscarinic, and adrenergic receptors, which means less sedation, dry mouth, and orthostatic hypotension compared to older antidepressants.
Escitalopram is one of the best-studied antidepressants, with strong evidence for both depression and generalized anxiety disorder [1, 2, 5, 7]. In the landmark Cipriani meta-analysis (2018), escitalopram was ranked among the most effective and most tolerable antidepressants out of 21 evaluated [2].
What to expect when starting Escitalopram
Starting escitalopram is generally a smooth experience compared to other antidepressants. Most patients begin at 10 mg once daily, and many find this is their therapeutic dose [1, 7].
In the first 1-2 weeks, you may experience mild nausea, headache, or sleep changes (insomnia or increased sleepiness). These are typically mild and resolve within 1-2 weeks [1]. Escitalopram is often considered the best-tolerated SSRI [2, 7].
Antidepressant effects take time. Some improvement in anxiety symptoms may occur within 1-2 weeks, but meaningful improvement in depression typically takes 2-4 weeks, with full effect by 6-8 weeks [1, 5, 7]. If 10 mg is insufficient, your doctor may increase to 20 mg/day.
Sexual side effects (decreased libido, difficulty reaching orgasm) can occur but may be less frequent than with some other SSRIs [1, 2]. However, individual responses vary significantly.
Escitalopram has important QTc prolongation concerns at higher doses. The FDA recommends a maximum dose of 20 mg/day, and 10 mg/day for elderly patients and those with hepatic impairment [1, 3]. Patients with pre-existing QTc prolongation, congestive heart failure, or those taking other QTc-prolonging medications should be monitored [3].
As with all SSRIs, do not stop escitalopram abruptly. Taper gradually under medical supervision to avoid discontinuation syndrome [10].
What are the common side effects of Escitalopram?
Common
- Nausea15%
- Insomnia9%
- Ejaculation disorder9% (male patients)
- Somnolence (drowsiness)6%
- Increased sweating5%
- Fatigue5%
- Diarrhea8%
- Dry mouth6%
- Dizziness5%
- Decreased libido3-7% (likely underreported; up to 25-30% in clinical practice)
- Headache24% (similar to placebo rate of 17%)
What are the serious side effects of Escitalopram?
Serious
- Hyponatremia (SIADH)Uncommon; higher risk in elderly, female patients, and those on diuretics
- Abnormal bleedingIncreased risk with NSAIDs or anticoagulants
- Mania/hypomania activationUncommon; higher risk in undiagnosed bipolar disorder
- Suicidal thoughts/behavior (in patients under 25)Approximately 4% vs 2% placebo in clinical trials
- QTc prolongation / Torsades de PointesDose-dependent; risk increases above 20 mg/day and with other QT-prolonging drugs
- Serotonin syndromeRare with monotherapy; risk increases with serotonergic drug combinations
What drugs interact with Escitalopram?
- ContraindicatedMAOIs (phenelzine, tranylcypromine, selegiline) — Combining escitalopram with MAOIs can trigger fatal serotonin syndrome. Allow at least 14 days washout between stopping an MAOI and starting escitalopram.
- ContraindicatedLinezolid (Zyvox) — Linezolid has MAOI activity and concurrent use with escitalopram can cause serotonin syndrome. Avoid combination unless the infection is life-threatening with no alternatives.
- ContraindicatedPimozide (Orap) — Escitalopram increases pimozide levels, prolonging the QT interval and increasing the risk of torsades de pointes. Concurrent use is contraindicated.
- MajorTramadol (Ultram) — Tramadol has serotonergic properties. Combined use with escitalopram raises the risk of serotonin syndrome and seizures. Use an alternative analgesic when possible.
- ModerateTriptans (sumatriptan, rizatriptan) — Triptans activate serotonin receptors. Concurrent use with escitalopram may increase serotonin syndrome risk, though clinically significant cases are uncommon.
- ModerateNSAIDs (ibuprofen, naproxen) — Escitalopram impairs platelet function, and NSAIDs increase GI bleeding risk. Consider a PPI for gastroprotection if both are needed.
- ModerateCimetidine (Tagamet) — Cimetidine inhibits CYP enzymes and can increase escitalopram plasma levels by approximately 72%. Consider an alternative H2 blocker such as famotidine.
- ModerateLithium (Lithobid) — Lithium augmentation with escitalopram can enhance antidepressant effect but also increases serotonin syndrome risk. Monitor lithium levels and serotonergic symptoms.
Can I eat certain foods or drink alcohol with Escitalopram?
Escitalopram can be taken with or without food; absorption is not affected by food [1].
Alcohol: Avoid alcohol or use it cautiously. Alcohol is a CNS depressant that can worsen depression and anxiety, and may increase drowsiness when combined with escitalopram [1]. The FDA labeling advises against alcohol use.
No significant food interactions. Grapefruit does not have a clinically significant interaction with escitalopram at usual doses [1].
Drug interactions to be aware of [1]: Escitalopram has relatively few pharmacokinetic drug interactions compared to other SSRIs (it is a weak inhibitor of CYP2D6). However, serotonergic drug combinations (MAOIs, tramadol, triptans, other SSRIs/SNRIs) increase the risk of serotonin syndrome and should be avoided or monitored carefully [1]. QTc-prolonging drugs (certain antiarrhythmics, antipsychotics, fluoroquinolones) should be combined cautiously [1, 3].
What is the typical dosage for Escitalopram?
Escitalopram is taken once daily, in the morning or evening [1].
Major Depressive Disorder (adults) [1, 7]: - Starting dose: 10 mg once daily - May increase to 20 mg/day after minimum 1 week - Recommended dose: 10-20 mg/day - Maximum: 20 mg/day
Generalized Anxiety Disorder (adults) [1, 5]: - Starting dose: 10 mg once daily - Recommended dose: 10-20 mg/day
MDD in Adolescents (ages 12-17) [1]: - Starting dose: 10 mg once daily - May increase to 20 mg/day after minimum 3 weeks
Special Populations [1, 3, 9]: - Elderly (>65 years): Maximum 10 mg/day (QTc concerns) - Hepatic impairment: Maximum 10 mg/day - CYP2C19 poor metabolizers: Maximum 10 mg/day - Severe renal impairment: Use with caution; no dose adjustment per label
Important QTc Note [1, 3]: Doses above 20 mg/day are not recommended due to dose-dependent QTc prolongation (this FDA limitation was applied to citalopram at 40 mg, equivalent to escitalopram 20 mg).
Discontinuation [10]: Taper gradually over at least 2-4 weeks.
How much does Escitalopram cost?
Escitalopram is available as an affordable generic since 2012 [1].
Generic pricing: $4-$12 per month for a 30-day supply at most pharmacies. Available on most $4 generic lists.
Brand Lexapro: Rarely prescribed as brand; costs $300-$450/month. No advantage over generic [1].
Insurance: Tier 1 on virtually all formularies.
Cost comparison with citalopram: Generic citalopram is equally affordable ($4-$8/month). Since escitalopram 10 mg is therapeutically equivalent to citalopram 20 mg, the choice between them is clinical, not financial [1, 4].
Is Escitalopram safe during pregnancy or breastfeeding?
Pregnancy: Escitalopram has less pregnancy-specific data than sertraline, but the available evidence (including data on citalopram, which contains escitalopram) does not indicate a major teratogenic risk [1, 7]. Third-trimester exposure may cause neonatal adaptation syndrome [1]. As with all SSRIs, the decision to use escitalopram during pregnancy requires balancing the risks of medication exposure against the risks of untreated depression.
If an SSRI is needed in pregnancy, sertraline is often preferred due to more extensive pregnancy-specific data [1, 7]. However, if a patient is well-controlled on escitalopram and switching poses risks of relapse, continuing escitalopram may be appropriate with informed consent.
Breastfeeding: Escitalopram is excreted in breast milk. The relative infant dose is approximately 5-8% of the maternal weight-adjusted dose, which is higher than sertraline but still generally considered acceptable [11]. Rare case reports of infant drowsiness and poor feeding have been reported. Sertraline is often preferred for breastfeeding due to lower relative infant doses [11].
Is there a generic version of Escitalopram?
Generic escitalopram (available since March 2012) is the standard. There is no reason to use brand Lexapro [1].
- Generic escitalopram: $4-$12/month. FDA AB-rated. Multiple manufacturers. - Brand Lexapro: $300-$450/month. Same drug.
Available forms [1]: Tablets (5, 10, 20 mg) and oral solution (1 mg/mL).
Escitalopram vs. Citalopram [1, 4]: Escitalopram is the active half of citalopram. Escitalopram 10 mg is approximately equivalent to citalopram 20 mg. Both are now generic and inexpensive. The main clinical difference: citalopram has a lower dose ceiling (40 mg, or 20 mg in elderly) due to QTc concerns, while escitalopram's ceiling is 20 mg (10 mg in elderly) [1, 3].
For Caregivers
If you are a caregiver for someone taking escitalopram [1, 6, 7]:
Monitor mood in the first months: Watch for worsening depression, agitation, or suicidal thoughts, especially in patients under 25 and during the first 2 months or after dose changes [6].
QTc awareness: Escitalopram can prolong the QT interval, which is a heart rhythm concern [1, 3]. Ensure the person is not exceeding the maximum dose (20 mg/day, or 10 mg/day for elderly). Report palpitations, fainting, or dizziness to the doctor.
Gradual discontinuation: Do not allow abrupt stopping. Ensure medication supply does not run out [10].
Drug interactions: Escitalopram has relatively few drug interactions compared to other SSRIs, which is an advantage [1]. However, always inform all healthcare providers about its use, especially before anesthesia or new medications.
Hyponatremia in elderly: Older adults are at higher risk for low sodium levels (SIADH) [8]. Watch for confusion, weakness, unsteadiness, or falls — these may indicate hyponatremia and should be reported to the doctor [8].
Frequently asked questions about Escitalopram
References
- [Regulatory] FDA prescribing information for Escitalopram Oxalate Tablets (Lexapro). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021323s047lbl.pdf Accessed 2025-01-15.
- [Clinical] Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder. Lancet. 2018;391(10128):1357-1366. https://pubmed.ncbi.nlm.nih.gov/29477251/ Accessed 2025-01-15.
- [Regulatory] FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to abnormal heart rhythms with high doses. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-revised-recommendations-celexa-citalopram-hydrobromide-related-abnormal Accessed 2025-01-15.
- [Clinical] Sanchez C et al. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl). 2004;174(2):163-176. https://pubmed.ncbi.nlm.nih.gov/15205879/ Accessed 2025-01-15.
- [Clinical] Baldwin DS et al. Efficacy of escitalopram in the treatment of generalized anxiety disorder: a systematic review. CNS Spectr. 2006;11(10 Suppl 12):1-12. https://pubmed.ncbi.nlm.nih.gov/17008828/ Accessed 2025-01-15.
- [Regulatory] FDA: Suicidality in Children and Adolescents Being Treated With Antidepressant Medications. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications Accessed 2025-01-15.
- [Regulatory] American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition. Am J Psychiatry. 2010;167(10 Suppl). https://pubmed.ncbi.nlm.nih.gov/20975158/ Accessed 2025-01-15.
- [Clinical] De Picker L et al. Antidepressants and the risk of hyponatremia: a class-by-class review of literature. Psychosomatics. 2014;55(6):536-547. https://pubmed.ncbi.nlm.nih.gov/25262043/ Accessed 2025-01-15.
- [Clinical] Rudberg I et al. Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther. 2008;83(2):322-327. https://pubmed.ncbi.nlm.nih.gov/17625514/ Accessed 2025-01-15.
- [Clinical] Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017;189(21):E747. https://pubmed.ncbi.nlm.nih.gov/28554948/ Accessed 2025-01-15.
- [Regulatory] National Library of Medicine. Drugs and Lactation Database (LactMed): Escitalopram. https://www.ncbi.nlm.nih.gov/books/NBK501238/ Accessed 2025-01-15.
- [Observational] DrugBank entry for Escitalopram (DB01175). https://go.drugbank.com/drugs/DB01175 Accessed 2025-01-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: